Group Returns to Organic Sales Growth

Thanks to the good business performance of Healthcare and Electronics, Group sales in the second quarter of 2024 increased by 1.7% organically.

Key facts and Forecast

Financial results of Q2 2024

  • Group net sales up organically by 1.7% to € 5.4 billion
  • EBITDA pre down 0.8% organically to € 1.5 billion against high comparative base
  • Healthcare and Electronics deliver organic sales growth
  • Market for AI semiconductor materials reaches inflection
  • Order intake in Process Solutions continues to improve sequentially and year-on-year

Forecast for fiscal 2024

  • Company raises guidance for the Group as well as for the Healthcare and Electronics business sectors
  • Net sales: in a range of € 20.7 billion to € 22.1 billion; organic growth of +2% to +5%
  • EBITDA pre: in a range of € 5.8 billion to € 6.4 billion; organic growth of +4% to +10%

Overview: business performance in Q2 2024

 

Q2 2024 (in € billion)

Change (in %, compared to Q2 2023)

Organic change  (in %, compared to Q2 2023)

Group net sales

5.4        

0.9

1.7

EBITDA pre

1.5        

‑2.9

‑0.8

Life Science sales

2.3

-4.1

-3.7

Healthcare sales

2.1

4.3

5.3

Electronics sales

1.0

6.5

7.6

Belén Garijo - Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany Belén Garijo - Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

“We announced that we would gradually return to organic growth during the course of 2024. The second quarter shows our progress on this journey."

Belén Garijo

Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

Conference calls for the media and analysts

Related News

View All News
  1. Press Releases

    Return to Organic Sales Growth

    Thanks to the good business performance of Healthcare and Electronics, Group sales in the second quarter of 2024 increased by 1.7% organically.

    2024/08/01

Upcoming Events

View All Events

Esther Döringer

Media Relations

Constantin Fest

Head of Investor Relations

+49 6151 72-5271

+49 6151 72 91-5271

Annual Reports Archive

Find previous Annual Reports, Corporate Governance Reports & Statements in our archive.
Read more

Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.

Check Share Price